• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

hsa-miR-424-5 通过 mTORC 信号通路与 PD-1 结合,刺激免疫效应并参与 1 型糖尿病的机制。

The mechanism of hsa-miR-424-5 combining PD-1 through mTORC signaling pathway to stimulate immune effect and participate in Type 1 diabetes.

机构信息

Department of Endocrinology, The Affiliated Lianyungang Hospital of Xuzhou Medical University, The First People's Hospital of Lianyungang, Lianyungang Clinical College of Nanjing Medical University, Lianyungang 222000, China.

Department of Gastrointestinal Surgery, The Affiliated Lianyungang Hospital of Xuzhou Medical University, The First People's Hospital of Lianyungang, Lianyungang Clinical College of Nanjing Medical University, Lianyungang 222000, China.

出版信息

Biosci Rep. 2020 Mar 27;40(3). doi: 10.1042/BSR20193800.

DOI:10.1042/BSR20193800
PMID:32010928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7070146/
Abstract

In the present study, hsa-miR-424-5p mimic plasmid and hsa-mir-424-5p inhibitor plasmid were designed and injected into rats respectively, and miRNA control plasmid was also constructed. Models of Type 1 diabetes (T1D) were built. After successful modeling, the expression of hsa-miR-424-5p in lymphocytes was analyzed by RT-PCR. The expression of protein PD-1, T-bet, CXCR3, STING in Th1 lymphocytes and content of IGF-1 in islet tissue were analyzed by flow analysis. The protein levels of SHP2, Rheb, mTORC1, Rictor and Raptor in islet tissue were analyzed by Western blot. The results showed that hsa-miR-424-5p mimic group had the highest expression of hsa-miR-424-5p in lymphocytes. The expression of PD-1 was in hsa-miR-424-5p inhibitor > miRNA control > hsa-miR-424-5p mimic, while the expression of T-bet, CXCR3 and STING was in hsa-miR-424-5p mimic > miRNA control > hsa-miR-424-5p inhibitor. The expression of IGF-1 protein in hsa-miR-424-5p inhibitor group was the highest (32.08%) and hardly expressed in hsa-miR-424-5p mimic group (2.36%). The expression of SHP2, Rheb, mTORC1, Rictor and Raptor of insulin histoproteins were in hsa-miR-424-5p mimic group > miRNA control of > hsa-miR-424-5p inhibitor group, with statistical differences. It indicates that hsa-miR-424-5p binding PD-1 signaling molecules can stimulate the immune effect through the mTORC signaling pathway and participates in the pathogenesis of T1D.

摘要

在本研究中,分别设计了 hsa-miR-424-5p 模拟质粒和 hsa-mir-424-5p 抑制剂质粒,并构建了 miRNA 对照质粒。构建 1 型糖尿病(T1D)模型。建模成功后,通过 RT-PCR 分析淋巴细胞中 hsa-miR-424-5p 的表达。通过流式分析分析 Th1 淋巴细胞中 PD-1、T-bet、CXCR3、STING 的表达以及胰岛组织中 IGF-1 的含量。通过 Western blot 分析胰岛组织中 SHP2、Rheb、mTORC1、Rictor 和 Raptor 的蛋白水平。结果表明,hsa-miR-424-5p 模拟组淋巴细胞中 hsa-miR-424-5p 表达最高。PD-1 的表达为 hsa-miR-424-5p 抑制剂>miRNA 对照>hsa-miR-424-5p 模拟,而 T-bet、CXCR3 和 STING 的表达为 hsa-miR-424-5p 模拟>miRNA 对照>hsa-miR-424-5p 抑制剂。hsa-miR-424-5p 抑制剂组 IGF-1 蛋白表达最高(32.08%),hsa-miR-424-5p 模拟组几乎不表达(2.36%)。胰岛素组织蛋白 SHP2、Rheb、mTORC1、Rictor 和 Raptor 的表达为 hsa-miR-424-5p 模拟组>miRNA 对照组>hsa-miR-424-5p 抑制剂组,差异有统计学意义。表明 hsa-miR-424-5p 结合 PD-1 信号分子,通过 mTORC 信号通路刺激免疫效应,参与 T1D 的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc1b/7070146/aa1f8383cdb0/bsr-40-bsr20193800-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc1b/7070146/880bcfc87381/bsr-40-bsr20193800-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc1b/7070146/f366ac09bdbd/bsr-40-bsr20193800-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc1b/7070146/e00cc6c778b4/bsr-40-bsr20193800-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc1b/7070146/217378113a90/bsr-40-bsr20193800-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc1b/7070146/aa1f8383cdb0/bsr-40-bsr20193800-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc1b/7070146/880bcfc87381/bsr-40-bsr20193800-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc1b/7070146/f366ac09bdbd/bsr-40-bsr20193800-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc1b/7070146/e00cc6c778b4/bsr-40-bsr20193800-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc1b/7070146/217378113a90/bsr-40-bsr20193800-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc1b/7070146/aa1f8383cdb0/bsr-40-bsr20193800-g5.jpg

相似文献

1
The mechanism of hsa-miR-424-5 combining PD-1 through mTORC signaling pathway to stimulate immune effect and participate in Type 1 diabetes.hsa-miR-424-5 通过 mTORC 信号通路与 PD-1 结合,刺激免疫效应并参与 1 型糖尿病的机制。
Biosci Rep. 2020 Mar 27;40(3). doi: 10.1042/BSR20193800.
2
miR-155-5p alleviates ethanol-induced myocardial insulin resistance in H9C2 cells via regulating the mTOR signalling pathway.miR-155-5p 通过调控 mTOR 信号通路减轻乙醇诱导的 H9C2 心肌细胞胰岛素抵抗。
Mol Biol Rep. 2020 Dec;47(12):9469-9477. doi: 10.1007/s11033-020-05967-6. Epub 2020 Nov 7.
3
Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.沉默 miR-202-5p 对 PIK3CA 基因表达的影响通过抑制 PI3K/Akt/mTOR 信号通路的激活对宫颈癌 SiHa 细胞的增殖、侵袭和上皮间质转化的作用。
Mol Cell Biochem. 2021 Nov;476(11):4031-4044. doi: 10.1007/s11010-021-04211-4. Epub 2021 Jul 9.
4
Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.miR-122-5p 通过靶向 TP53 基因调控 PI3K-Akt-mTOR 信号通路对骨肉瘤细胞增殖和凋亡的作用机制。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):12655-12666. doi: 10.26355/eurrev_202012_24163.
5
Expression of Concern: The mechanism of hsa-miR-424-5 combining PD-1 through mTORC signaling pathway to stimulate immune effect and participate in type 1 diabetes.关注声明:hsa-miR-424-5通过mTORC信号通路结合PD-1以刺激免疫效应并参与1型糖尿病的机制。
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR-20193800_EOC.
6
Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.鉴定1型、2型和妊娠期糖尿病患者外周血单个核细胞中表达的常见和特异性微小RNA。
BMC Res Notes. 2013 Nov 26;6:491. doi: 10.1186/1756-0500-6-491.
7
[Identification of onco-miRNAs in hepatocellular carcinoma and analysis of their regulatory network].[肝细胞癌中癌基因miRNA的鉴定及其调控网络分析]
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Jan 20;42(1):45-54. doi: 10.12122/j.issn.1673-4254.2022.01.05.
8
Retraction: The mechanism of hsa-miR-424-5 combining PD-1 through mTORC signaling pathway to stimulate immune effect and participate in type 1 diabetes.撤稿声明:hsa-miR-424-5通过mTORC信号通路结合PD-1以刺激免疫效应并参与1型糖尿病的机制
Biosci Rep. 2022 Nov 30;42(11). doi: 10.1042/BSR-2019-3800_RET.
9
[Bioinformatics analysis of the microRNA expression profile in the peripheral blood lymphocytes of Kazakh patients with essential hypertension in Xinjiang].[新疆哈萨克族原发性高血压患者外周血淋巴细胞中微小RNA表达谱的生物信息学分析]
Sheng Li Xue Bao. 2022 Oct 25;74(5):751-762.
10
Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.miR-424-5p 通过靶向 PD-L1 并调节 PTEN/PI3K/AKT/mTOR 信号通路抑制乳腺癌细胞中的肿瘤发生活性。
Life Sci. 2020 Oct 15;259:118239. doi: 10.1016/j.lfs.2020.118239. Epub 2020 Aug 10.

引用本文的文献

1
Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.运用生物信息学分析鉴定 C1QB、ITGAM 和 ITGB2 为糖尿病肾病的潜在诊断候选基因。
PeerJ. 2023 May 25;11:e15437. doi: 10.7717/peerj.15437. eCollection 2023.
2
Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy.靶向蛋白磷酸酶治疗炎症相关疾病:从信号转导到治疗。
Signal Transduct Target Ther. 2022 Jun 4;7(1):177. doi: 10.1038/s41392-022-01038-3.
3
Interplay Between Non-Coding RNAs and Programmed Cell Death Proteins.

本文引用的文献

1
The Role of Insulin-Like Growth Factors and Insulin-Like Growth Factor-Binding Proteins in the Nervous System.胰岛素样生长因子及胰岛素样生长因子结合蛋白在神经系统中的作用
Biochem Insights. 2019 Apr 17;12:1178626419842176. doi: 10.1177/1178626419842176. eCollection 2019.
2
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.达格列净治疗 1 型糖尿病血糖控制不佳患者的疗效和安全性(DEPICT-2 研究):一项随机对照试验的 24 周结果。
Diabetes Care. 2018 Sep;41(9):1938-1946. doi: 10.2337/dc18-0623. Epub 2018 Jul 19.
3
非编码RNA与程序性细胞死亡蛋白之间的相互作用
Front Oncol. 2022 Mar 23;12:808475. doi: 10.3389/fonc.2022.808475. eCollection 2022.
4
Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1/2 and other parameters of vascular health.1 型糖尿病(亚临床心血管疾病模型)中上调的抗血管生成 miR-424-5p 与内皮祖细胞、CXCR1/2 及其他血管健康参数相关。
Stem Cell Res Ther. 2021 May 14;12(1):249. doi: 10.1186/s13287-021-02332-7.
Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study.
索格列净联合优化胰岛素治疗在成人 1 型糖尿病中的应用:北美 inTandem1 研究。
Diabetes Care. 2018 Sep;41(9):1970-1980. doi: 10.2337/dc18-0343. Epub 2018 Jun 24.
4
Preserving Treg Function: Beyond mTOR Inhibitors.保留调节性T细胞功能:超越雷帕霉素靶蛋白抑制剂
Transplantation. 2018 Feb;102(2):179-182. doi: 10.1097/TP.0000000000002042.
5
mTORC2 Promotes Tumorigenesis via Lipid Synthesis.mTORC2 通过脂质合成促进肿瘤发生。
Cancer Cell. 2017 Dec 11;32(6):807-823.e12. doi: 10.1016/j.ccell.2017.11.011.
6
mTOR Signaling in Growth, Metabolism, and Disease.生长、代谢及疾病中的mTOR信号传导
Cell. 2017 Mar 9;168(6):960-976. doi: 10.1016/j.cell.2017.02.004.
7
mTORC1 and mTORC2 in cancer and the tumor microenvironment.癌症及肿瘤微环境中的mTORC1和mTORC2
Oncogene. 2017 Apr 20;36(16):2191-2201. doi: 10.1038/onc.2016.363. Epub 2016 Oct 17.
8
The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy.2型糖尿病患者Th1/Th2/Th17/Treg模式的改变:与糖尿病肾病的关系
Hum Immunol. 2014 Apr;75(4):289-96. doi: 10.1016/j.humimm.2014.02.007. Epub 2014 Feb 12.
9
mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function.mTORC1 将免疫信号和代谢编程联系起来,以建立 T(调节)细胞的功能。
Nature. 2013 Jul 25;499(7459):485-90. doi: 10.1038/nature12297. Epub 2013 Jun 30.
10
Inflammation and the pathogenesis of diabetic nephropathy.炎症与糖尿病肾病发病机制。
Clin Sci (Lond). 2013 Feb;124(3):139-52. doi: 10.1042/CS20120198.